Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma

Table 4 Logistic regression estimates of odds ratios for pathologic stage T2 hepatocellular carcinoma in patients with solitary tumor on Gd-EOB-DTPA-enhanced magnetic resonance imaging

Combinations of aggressive features	Number of pT2 patients	OR (95%CI)
A = 0 and B = 0 and C = 0	4	Reference
Only A or Only B or Only C	10	1.037 (0.285-3.766)
A + B or B + C or A + C or A + B + C	25	6.250 (1.788-21.845)

Gd-EOB-DTPA: Gadolinium ethoxybenzyl diethylene-triaminepentaacetic acid; A = 0: Tumor size < 2.3 cm; B = 0: No peritumoral hypointensity on hepatobiliary phase; C = 0: No corona enhancement; A: Tumor size ≥ 2.3 cm; B: Presence of peritumoral hypointensity on hepatobiliary phase; C: Presence of corona enhancement; OR: Odds ratio; CI: Confidence interval.